Dissolution [Dissolution / BCS / IVIVC]

posted by jag009  – NJ, 2014-08-22 18:47 (4317 d 06:10 ago) – Posting: # 13419
Views: 10,983

Guys and Girls,

A question... Suppose you have an IR drug product which is highly soluble but poor in permeability and has a Tmax of 8 hrs. Do you think slowing down the rate of in-vitro release will affect the overall PK?

Assume this scenario...
Under the same dissolution medium, assuming the reference is releasing no less than 80% at 30 mins, and your product is releasing no less than 80% at 60 mins. What do you think?

Thanks
John

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
281 visitors (0 registered, 281 guests [including 135 identified bots]).
Forum time: 00:58 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5